This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
n18	http://linked.opendata.cz/resource/sukl/roa/
n2	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dcterms	http://purl.org/dc/terms/
n3	http://linked.opendata.cz/ontology/sukl/
n7	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0192559/price-of-originator/
n6	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0192559/reimbursement/
n13	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0192559/
skos	http://www.w3.org/2004/02/skos/core#
n5	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0192559/core-reimbursement/
n20	http://linked.opendata.cz/resource/sukl/indgroup/
n14	http://linked.opendata.cz/resource/sukl/packing/
n16	http://linked.opendata.cz/resource/sukl/company/
n4	http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0192559/price/
n15	http://linked.opendata.cz/resource/sukl/active-ingredient/
n19	http://linked.opendata.cz/resource/sukl/specialization-restriction/http://linked.opendata.cz/ontology/odcs/tabular/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n9	http://linked.opendata.cz/resource/sukl/registration-state/
xsdh	http://www.w3.org/2001/XMLSchema#
n8	http://www.sukl.cz/modules/medication/
n12	http://linked.opendata.cz/resource/atc/
n10	http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item

n2:0192559

rdf:type

n3:MedicinalProductPackaging

dcterms:title

ANTITHROMBIN III NF BAXTER

skos:notation

0192559

n3:hasATCCode

n12:B01AB02

n3:hasActiveIngredient

n15:PROTEINA n15:ANTITHROMBINUM-III

n3:hasDefinedDailyDose

n13:ddd

n3:hasDosageForm

n10:PSO-LQF-INF

n3:hasPackagingSize

1+1X20ML

n3:hasPacking

n14:VIA

n3:hasRegistrationHolder

n16:BXGA

n3:hasRegistrationState

n9:R

n3:hasRouteOfAdministration

n18:INF

n3:hasStrength

50IU/ML

n3:hasIndicationGroup

n20:16

n3:hasSpecializationRestriction

n19:blank-cell

n3:containsDefinedDailyDoses

0.47600001096725463867

n3:hasRegistrationCode

16/ 144/89-C

n3:hasTitleSupplement

INF PSO LQF 1+1X20ML

n3:containsUsualTherapeuticalDailyDoses

0.4762

n3:hasCoreReimbursementSpecification

n5:2015-07-01 n5:2015-07-02 n5:2014-06-13 n5:2014-07-01 n5:2014-05-01 n5:2014-06-01 n5:2014-03-01 n5:2014-04-01 n5:2014-01-01 n5:2014-02-01 n5:2014-11-19 n5:2014-12-01 n5:2014-10-02 n5:2014-11-01 n5:2014-09-01 n5:2014-10-01 n5:2014-07-03 n5:2014-08-01 n5:2013-04-01 n5:2013-05-01 n5:2013-02-01 n5:2013-03-01 n5:2013-01-01 n5:2013-01-05 n5:2013-11-01 n5:2013-12-01 n5:2013-09-01 n5:2013-10-01 n5:2013-08-01 n5:2013-08-03 n5:2013-06-01 n5:2013-07-01 n5:2015-05-01 n5:2015-06-01 n5:2015-04-01 n5:2015-04-02 n5:2015-02-01 n5:2015-03-01 n5:2015-01-01 n5:2015-01-13

n3:hasPriceOfOriginatorSpecification

n7:2015-07-01 n7:2015-07-02 n7:2014-03-01 n7:2014-04-01 n7:2014-01-01 n7:2014-02-01 n7:2014-06-13 n7:2014-07-01 n7:2014-05-01 n7:2014-06-01 n7:2013-08-01 n7:2013-08-03 n7:2013-06-01 n7:2013-07-01 n7:2013-11-01 n7:2013-12-01 n7:2013-09-01 n7:2013-10-01 n7:2015-02-01 n7:2015-03-01 n7:2015-01-01 n7:2015-01-13 n7:2015-05-01 n7:2015-06-01 n7:2015-04-01 n7:2015-04-02 n7:2014-09-01 n7:2014-10-01 n7:2014-07-03 n7:2014-08-01 n7:2014-11-19 n7:2014-12-01 n7:2014-10-02 n7:2014-11-01 n7:2013-01-01 n7:2013-01-05 n7:2013-04-01 n7:2013-05-01 n7:2013-02-01 n7:2013-03-01

n3:hasPriceSpecification

n4:2015-02-01 n4:2015-03-01 n4:2013-09-01 n4:2013-10-01 n4:2013-11-01 n4:2013-12-01 n4:2013-06-01 n4:2013-07-01 n4:2013-08-01 n4:2013-08-03 n4:2013-02-01 n4:2013-03-01 n4:2013-04-01 n4:2013-05-01 n4:2013-01-01 n4:2013-01-05 n4:2014-10-02 n4:2014-11-01 n4:2014-11-19 n4:2014-12-01 n4:2014-07-03 n4:2014-08-01 n4:2014-09-01 n4:2014-10-01 n4:2014-05-01 n4:2014-06-01 n4:2014-06-13 n4:2014-07-01 n4:2014-01-01 n4:2014-02-01 n4:2014-03-01 n4:2014-04-01 n4:2015-07-01 n4:2015-07-02 n4:2015-04-01 n4:2015-04-02 n4:2015-05-01 n4:2015-06-01 n4:2015-01-01 n4:2015-01-13

n3:hasReimbursementSpecification

n6:2014-06-13 n6:2014-07-01 n6:2014-05-01 n6:2014-06-01 n6:2014-03-01 n6:2014-04-01 n6:2014-01-01 n6:2014-02-01 n6:2013-11-01 n6:2013-12-01 n6:2013-09-01 n6:2013-10-01 n6:2013-08-01 n6:2013-08-03 n6:2013-06-01 n6:2013-07-01 n6:2015-05-01 n6:2015-06-01 n6:2015-04-01 n6:2015-04-02 n6:2015-02-01 n6:2015-03-01 n6:2015-01-01 n6:2015-01-13 n6:2014-11-19 n6:2014-12-01 n6:2014-10-02 n6:2014-11-01 n6:2014-09-01 n6:2014-10-01 n6:2014-07-03 n6:2014-08-01 n6:2015-07-01 n6:2015-07-02 n6:2013-04-01 n6:2013-05-01 n6:2013-02-01 n6:2013-03-01 n6:2013-01-01 n6:2013-01-05

n3:hasResumedMarketingDate

2013-01-03+01:00

n3:hasUsualTherapeuticalDailyDose

n13:utdd

n3:spcFile

http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC32538.pdf%26type%3Dspc%26as%3Dantithrombin-iii-nf-baxter-spc

n3:spcUri

n8:download.php?file=SPC32538.pdf&type=spc&as=antithrombin-iii-nf-baxter-spc